A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Edoxaban Impurity 173 - Request Quote

Picture of Edoxaban Impurity 173

Edoxaban Impurity 173

SZ CAT No:SZ-E041220
CAS No
NA
Mol.F.
C26H47N5O6
Mol.Wt.
525.7
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Edoxaban Impurity 173 is chemically Tert-butyl ((1R,2S,5S)-2-amino-5-(((1S,2R,4S)-2-((tert-butoxycarbonyl)amino)-4-(dimethylcarbamoyl)cyclohexyl)carbamoyl)cyclohexyl)carbamate. Edoxaban Impurity 173 is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 173 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Edoxaban Impurity 173

Purchase Edoxaban Impurity 173

Edoxaban Impurity 173 suppliers

Edoxaban Impurity 173 manufacturers

Edoxaban Impurity 173 price

Order Edoxaban Impurity 173

Enquire Edoxaban Impurity 173

Edoxaban Impurity 173 cost

Edoxaban Impurity 173 Supplier

Edoxaban Impurity 173 Distributor

Edoxaban Impurity 173 for Method Validation

Edoxaban Reference Standard

Edoxaban Impurity 173 for ANDA Filing

Edoxaban Impurity 173 for Forced Degradation Studies

Edoxaban Impurity 173 Identification Standards

Edoxaban Impurity 173 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,